The Science of MS Management: Update on Progressive Forms of Multiple Sclerosis
The Science of MS Management: Update on Progressive Forms of Multiple SclerosisCorey C. Ford, MD, PhD; Emmannuelle Waubant, MD, PhD…
New study will explore potential treatment (ibudilast )for progressive MS
PDF At this time, there is a significant gap in available treatment options for people living with progressive MS. The…
Stuart Schlossman
Different Goals, But a Continued Role, For Neurologists In Late Secondary Progressive MS
R. Philip Kinkel, MD Neurologists can and should continue to play an important role in the care of patients with…
Stuart Schlossman
Opexa Reaches Enrollment Target in Phase IIb Trial of Personalized Immunotherapy for Secondary Progressive Multiple Sclerosis
THE WOODLANDS, Texas–(BUSINESS WIRE)– May 13, 2014 Opexa Therapeutics, Inc. (OPXA), a biotechnology company developing Tcelna® (imilecleucel-T), a novel…
Stuart Schlossman
Tcelna Study for the Treatment of Secondary Progressive Multiple Sclerosis (MS)
Dr Daniel Kantor speaks with Dr Edward Fox from the MS Clinic in Central Texas, about the Tcelna study for…
Stuart Schlossman
PPMS Update: Slowing Down Primary Progressive Multiple Sclerosis Disability Progression Worth Safety Risks For New Drugs, Say Surveyed U.S. Neurologists
Posted by: Mike Nace April 11, 2014 Photo Credit: Designua/Shutterstock According to a recent wide-ranging survey among U.S.based neurologists who treat Multiple Sclerosis,…
Stuart Schlossman
Secondary Progressive MS Trial of Lamotrigine Tested For Neuroprotection Benefits
Posted by: Ayesha Khan January 31, 2014 A recently completed study at University College London Hospital suggests that administration of certain drugs…
Stuart Schlossman
Research showing advances in Axon restoration, cognitive performance, And a hopeful medication for Primary & Secondary-progressive multiple sclerosis
Posted by: Maureen Newman February 28, 2014 Fresh from the Multiple Sclerosis Association of America (MSAA) is the 2014 MS Research Update, published each year, MS…
Stuart Schlossman
Secondary Progressive Multiple Sclerosis EBV Adoptive Immunotherapy Shows Promise
Posted by: Maureen Newman February 10, 2014 Professor Michael Pender, of the University of Queensland School of Medicine, Brisbane,…
Stuart Schlossman
Secondary Progressive MS Research Into Natalizumab Continues To Progress
Posted by: Mike Nace February 6, 2014 Researchers continue to explore different treatment approaches for secondary progressive MS, ranging from the development…
Stuart Schlossman
